Cell And Gene Therapy Manufacturing
-
Rethinking Sustainability In Bioprocessing
5/22/2025
Discover how sustainability is transforming bioprocessing through innovative single-use technologies that help reduce environmental impact and support responsible, forward-thinking biomanufacturing.
-
Collaborating with the FDA: Dr. Peter Marks and Dr. Nicole Verdun Share Advice For Small And Emerging Biotechs
1/30/2024
In this segment, Dr. Peter Marks and Dr. Nicole Verdun share their advice and best practices for small and emerging biotechs when working with the FDA.
-
Bioprocessing Equipment And Automation Product Portfolio Overview
5/19/2025
Accelerate biotherapeutic development with innovative bioprocessing equipment and automation solutions that feature single-use mixers, bioreactors, and more to streamline workflows and speed products to market.
-
HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 3
5/7/2020
This video is part 3 of 3 videos that cover setup and installation topics related to the HyPerforma 5:1 Single-Use Bioreactor, or S.U.B. In this video we will cover probe assembly, making CPC AseptiQuik connections, probe insertion.
-
BPI Interviews Purification And Pharma Analytics Leader
6/9/2025
Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.
-
What Is The DynaChromâ„¢ Single-Use Chromatography System?
3/21/2024
This chromatography system offers a flexible solution, paired with an advanced software platform, allowing easy integration with downstream process automation.
-
Cell And Gene Therapy Innovations
5/19/2025
This interview with a pharmaceutical analytics expert discusses key insights into advances in cell and gene therapy and the strategies used to support customers in improving their therapeutic development.
-
Rapid Process Development And Technical Support For AAV Scaleup
12/17/2024
Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.
-
Patient Data's Impact On CMC Robustness
1/30/2024
When CGT products demonstrate dramatic improvements with minimal safety concerns in a Phase 2 study, sponsors may want to modify the protocol mid-study to increase patient enrollment.
-
Solutions For Diverse Biomolecule Purification
5/21/2025
Interview with Paul Lynch, Product Management Leader, Purification, discusses our chromatography resins and innovations in downstream purification processes.